BAILLIE GIFFORD & COBAILLIE GIFFORD & CO

Institutional investor · Portfolio as of Q2 2022

SEC EDGAR SourceSEC Filings

Top Holdings493 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MODERNA INC

45.6M$6.5B6.7%$116.88+22.19%
14 qtrssince 2019-Q1
Decreased
0

TESLA INC

9.4M$6.3B6.5%$98.71+131.49%
14 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

37.8M$4B4.1%$107.87+0.98%
14 qtrssince 2019-Q1
Increased
94

ILLUMINA INC

19.9M$3.7B3.8%$314.19-42.28%
14 qtrssince 2019-Q1
Decreased
0

MERCADOLIBRE INC

5.4M$3.5B3.5%$606.51+8.84%
14 qtrssince 2019-Q1
Increased
63

SPOTIFY TECHNOLOGY SA

26.2M$2.5B2.5%$143.89-31.92%
14 qtrssince 2019-Q1
Increased
62

NVIDIA CORP

15.3M$2.3B2.4%$16.68-6.98%
14 qtrssince 2019-Q1
Decreased
0
NIONIO
ADR

NIO INC

96.7M$2.1B2.2%$7.94+175.27%
14 qtrssince 2019-Q1
Increased
60

TRADE DESK INC/THE -CLASS A

47.1M$2B2.0%$76.84-43.60%
14 qtrssince 2019-Q1
Decreased
0

ANTHEM INC

4.1M$2B2.0%$287.50+60.60%
14 qtrssince 2019-Q1
Decreased
0

FERRARI NV

9.9M$1.8B1.9%$129.58+39.58%
14 qtrssince 2019-Q1
Decreased
0

SHOPIFY INC - CLASS A

57M$1.8B1.8%$32.26+2.45%
14 qtrssince 2019-Q1
Increased
81
PDDPDD
ADR

PDD HOLDINGS INC

28.1M$1.7B1.8%$48.85+29.10%
14 qtrssince 2019-Q1
Decreased
0

MICROSOFT CORP

6.3M$1.6B1.7%$124.17+103.70%
14 qtrssince 2019-Q1
Decreased
0

ALNYLAM PHARMACEUTICALS INC

10M$1.5B1.5%$101.98+43.01%
14 qtrssince 2019-Q1
Decreased
0

COUPANG INC

108.4M$1.4B1.4%$30.32-57.18%
6 qtrssince 2021-Q1
Decreased
0

DEXCOM INC

18.1M$1.3B1.4%$68.22+10.61%
14 qtrssince 2019-Q1
Increased
81

NETFLIX INC

7.5M$1.3B1.3%$37.13-51.96%
14 qtrssince 2019-Q1
Decreased
0

MOODY'S CORP

4.8M$1.3B1.3%$174.57+50.24%
14 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL C

590,775$1.3B1.3%$58.84+89.37%
14 qtrssince 2019-Q1
Decreased
0
$97.5B
AUM
493
Positions
Q2 2022
Filing
Rating · 3.5
Quarterly Portfolio Change
-1%Q1'21$178.7B+15%Q2'21$205.2B-7%Q3'21$191.1B-5%Q4'21$182.2B-22%Q1'22$142.7B-32%Q2'22$97.5B
Activity profile
$ moved · Q2'22
New0%Increased29%Decreased71%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q6%1-4Q13%1-2Y40%2Y+41%

BAILLIE GIFFORD & CO manages $97.5B across 493 positions as of Q2 2022. Top holdings: MRNA (6.7%), TSLA (6.5%), AMZN (4.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q2 2022 Summary

Active quarter - 32 new positions, 37 exits, 115 increased. Top move: AMZN (INCREASED, conviction 94). Portfolio: $97.5B across 493 positions.

Top holdings by portfolio weight

Total AUM$98B
MRNA6.67%
TSLA6.49%
AMZN4.12%
ILMN3.77%
MELI3.54%
SPOT2.52%
NVDA2.38%
NIO2.15%
TTD2.02%
ELV2.01%
Other1.86%

Portfolio allocation by GICS sector

Sectors11
Consumer Cyclical27.58%
Healthcare24.35%
Technology15.82%
Communication Services10.66%
Financial Services7.71%
Industrials3.49%
Unknown3.06%
Basic Materials2.59%
Consumer Defensive2.00%
Real Estate1.59%
Other1.16%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record54
Conviction41
Concentration67
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
ENSGENSGENSIGN GROUP INC/THE
Q2 2025 Q2 2026+4.1M shares+$683.8M
5Q
PMPMPHILIP MORRIS INTERNATIONAL
Q2 2025 Q2 2026+1.9M shares+$352.2M
3Q
BABABABAALIBABA GROUP HOLDING-SP ADR
Q4 2025 Q2 2026+424,416 shares+$10M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used